Industry News
Biotechnology Industry News
Protein that manipulates gene expression inside the cell nucleus could inspire new RSV drugs, vaccines
Protein that manipulates gene expression inside the cell nucleus could inspire new RSV drugs, vaccines klahucik Thu, 10/14/2021 - 10:23
Omega, eyeing new uses for genome-tuning tech, taps Stanford to find ocular disease targets
Omega, eyeing new uses for genome-tuning tech, taps Stanford to find ocular disease targets ntaylor Thu, 10/14/2021 - 08:48
OnKure sets Diamond in C-suite ahead of Pfizer drug combo trial
OnKure sets Diamond in C-suite ahead of Pfizer drug combo trial ntaylor Thu, 10/14/2021 - 08:03
After 15 years helping lead early cancer research at Genentech, Malek jumps ship to run Novartis’ NIBR oncology unit
After 15 years helping lead early cancer research at Genentech, Malek jumps ship to run Novartis' NIBR oncology unit badams Thu, 10/14/2021 - 04:33
Novel protein degrader against ‘undruggable’ cancer target inhibits tumors in mice
Novel protein degrader against 'undruggable' cancer target inhibits tumors in mice aliu Wed, 10/13/2021 - 13:01
Aum bags $27M to hit cancer targets pursued by Bayer, Roche
Aum bags $27M to hit cancer targets pursued by Bayer, Roche ntaylor Wed, 10/13/2021 - 08:32
Apnimed sees positives in midstage data for its attempt at drugging the sleep apnea problem
Apnimed sees positives in midstage data for its attempt at drugging the sleep apnea problem badams Wed, 10/13/2021 - 04:58
UPDATE: CRISPR hails safety, efficacy of off-the-shelf CAR-Ts, but stock slides amid durability doubts
UPDATE: CRISPR hails safety, efficacy of off-the-shelf CAR-Ts, but stock slides amid durability doubts ntaylor Wed, 10/13/2021 - 04:32
J&J science chief Stoffels to retire after decade at the top, adding to C-suite changes
J&J science chief Stoffels to retire after decade at the top, adding to C-suite changes ntaylor Tue, 10/12/2021 - 08:39
Boston biotech backers quit Dana-Farber board after U-turn on investment policy: report
Boston biotech backers quit Dana-Farber board after U-turn on investment policy: report ntaylor Tue, 10/12/2021 - 07:51
CureVac giving up on first COVID mRNA vax, focusing on GSK-partnered 2nd attempt
CureVac giving up on first COVID mRNA vax, focusing on GSK-partnered 2nd attempt badams Tue, 10/12/2021 - 07:29
A New Way to Access Scientific Papers?
A New Way to Access Scientific Papers? admin Mon, 10/11/2021 - 15:38
Brain atlas unveils dozens of cell types that control movement and could inspire targets in neurological disease
Brain atlas unveils dozens of cell types that control movement and could inspire targets in neurological disease arlene.weintraub Mon, 10/11/2021 - 08:50
Protagonist’s story gets a happy ending as FDA’s hold swiftly lifted on rusfertide program
Protagonist's story gets a happy ending as FDA's hold swiftly lifted on rusfertide program badams Mon, 10/11/2021 - 08:03
Merck makes beeline to FDA, seeking approval for COVID-19 antiviral 10 days after reporting data
Merck makes beeline to FDA, seeking approval for COVID-19 antiviral 10 days after reporting data ntaylor Mon, 10/11/2021 - 07:29
AstraZeneca’s COVID-19 therapy hits goal in phase 3, but efficacy falls short of rivals
AstraZeneca's COVID-19 therapy hits goal in phase 3, but efficacy falls short of rivals ntaylor Mon, 10/11/2021 - 05:10
Senate to cull Biden’s biomedical research agency from social care bill: Report
Senate to cull Biden's biomedical research agency from social care bill: Report badams Mon, 10/11/2021 - 04:03
Novel vaccine strategy protects mice from COVID-19 and 4 related coronaviruses
Novel vaccine strategy protects mice from COVID-19 and 4 related coronaviruses arlene.weintraub Fri, 10/08/2021 - 08:48
Pfizer, Bayer-backed Pyxis ups IPO price as biotech’s public run continues unabated
Pfizer, Bayer-backed Pyxis ups IPO price as biotech's public run continues unabated badams Fri, 10/08/2021 - 08:12
Takeda’s transplant drug gets unanimous support of FDA AdComm despite concerns over diversity of its study
Takeda's transplant drug gets unanimous support of FDA AdComm despite concerns over diversity of its study ntaylor Fri, 10/08/2021 - 05:07